5 days ago 5 key factors may predict stroke risk years after first event, study finds New research reveals five factors that may predict another stroke after a mini stroke, including hypertension, smoking and three specific stroke subtypes.
April 3 Common drinking habit may quietly triple risk of advanced liver condition Even occasional binge drinking could triple the risk of advanced liver fibrosis, a new USC study suggests, highlighting the danger of alcohol consumption patterns.
April 3 Breakthrough ALS study launches as drug aims to slow disease progression The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
April 3 GOP targets transgender animal testing in defund demand to NIH Republican lawmakers push to ban funding for transgender animal experiments in the 2027 Appropriations bill after NIH granted new research funds.
April 2 RFK Jr launches $134M+ national program to study microplastics in the human body, drinking water HHS and EPA announce a joint effort to tackle microplastics and pharmaceuticals in the nation's water supply, citing a growing public health crisis.
April 2 New weight-loss pill hits the market, promising 'greater flexibility' FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.
April 2 Does marijuana cause lung cancer? Doctors reveal what the research says New research suggests heavy marijuana smoking may raise the risk of lung cancer risk, as well as head and neck cancer. Research has also linked nicotine-based vaping to cancer risk.
April 1 Woman’s double-twin relationship sparks court’s impossible paternity ruling A UK Court of Appeals ruled that neither of two identical twins can be legally named the father of a child, as DNA testing cannot distinguish them.
March 31 Human trials underway for Fentanyl vaccine Fox News chief Washington correspondent Mike Emanuel reports on the life-saving impacts the drug could have on ‘America’s Newsroom.’
March 31 Aggressive brain cancer may respond to high-dose vitamin therapy, study suggests High-dose vitamin B3 (niacin) may boost immune function and slow glioblastoma progression, with 82% of trial patients showing no disease progression after six months.